Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- Spain
- France
- Sweden
- Poland
- Netherlands
- Portugal
- Italy
- Switzerland
- Canada
- Singapore
- Belgium
- Czech
- Japan
- Denmark
- Ireland
- Norway
- Austria
- Australia
- Morocco
- Finland
- Latvia
- Mexico
- United Arab Emirates
- Brazil
- Greece
- Hong Kong
- India
- Luxembourg
- Slovenia
- South Korea
- Taiwan
- 24 more »
- « less
-
Program
-
Field
-
the following areas (including but not limited to): Cell and tissue biology Tissue engineering Neuroscience Chemical biology Synthetic biology Biomaterial science Bioengineering Biomedical engineering
-
translational research program focused on extracellular matrix biology, musculoskeletal fibrosis, and tissue regeneration. Dr. Alex Lambi is a plastic and hand surgeon-scientist and cell/matrix biologist
-
and approaches to interrogate fundamental mechanistic questions at the molecular, cellular, tissue, and organismal levels. In addition to the world-class facilities available at the University
-
engineered in vitro model systems to investigate how the aging microenvironment regulates cell behavior and tissue function. More information about the lab and their work can be found by visiting https
-
tissue and blood-based liquid biopsies derived from unique and well-annotated clinical cohorts. Our research integrates advanced liquid biopsy approaches, including analysis of circulating tumor cells and
-
tissues to control inflammation and sensation. We work at the interface of tissue immunology and tissue neuroscience, asking how immune cells and the neurons that innervate an organ signal to one another
-
are particularly interested in the recovery and interpretation of DNA and proteins from historical tissues and in the development and application of multi-omic approaches that maximize the information obtained from
-
observe how new treatments interact with a living, beating heart. This lack of real‑time visibility slows progress in regenerative medicine, particularly for therapies such as engineered heart tissue (EHT
-
neurodegeneration, microglial activation, microglia-vascular interactions and angiogenesis, tissue injury and repair, and therapeutic response. The position will integrate in vivo ocular disease models, primary
-
challenging technologies for the repair of damaged organs and tissues. Within MERLN, the CTR department (https://merlninstitute.com/discover-merln/departments-and-groups/ctr-de… ) focuses on advanced macro